Norwegian Institute of Public Health, Oslo, Norway;
Norwegian Institute of Public Health, Oslo, Norway.
Pediatrics. 2018 Mar;141(3). doi: 10.1542/peds.2017-0752. Epub 2018 Feb 15.
To determine if pandemic influenza vaccination was associated with an increased risk of epilepsy in children.
Information from Norwegian registries from 2006 through 2014 on all children <18 years living in Norway on October 1, 2009 was used in Cox regression models to estimate hazard ratios for incident epilepsy after vaccination. A self-controlled case series analysis was used to estimate incidence rate ratios in defined risk periods after pandemic vaccination.
In Norway, the main period of the influenza A subtype H1N1 pandemic was from October 2009 to December 2009. On October 1, 2009, 1 154 113 children <18 years of age were registered as residents in Norway. Of these, 572 875 (50.7%) were vaccinated against pandemic influenza. From October 2009 through 2014 there were 3628 new cases of epilepsy (incidence rate 6.09 per 10 000 person-years). The risk of epilepsy was not increased after vaccination: hazard ratio: 1.07; 95% confidence interval: 0.94-1.23. Results from the self-controlled case series analysis supported the finding of no association between vaccination and subsequent epilepsy.
Pandemic influenza vaccination was not associated with increased risk of epilepsy. Concerns about pandemic vaccination causing epilepsy in children seem to be unwarranted.
确定大流行性流感疫苗接种是否与儿童癫痫风险增加相关。
使用来自挪威登记处的 2006 年至 2014 年的信息,对 2009 年 10 月 1 日居住在挪威的所有<18 岁儿童进行 Cox 回归模型分析,以估计接种疫苗后癫痫发作的风险比。采用自我对照病例系列分析来估计大流行疫苗接种后的特定风险期的发病率比。
在挪威,甲型 H1N1 大流行性流感亚型的主要流行期为 2009 年 10 月至 12 月。2009 年 10 月 1 日,有 1 154 113 名<18 岁的儿童在挪威登记为居民。其中,有 572 875 名(50.7%)接种了大流行性流感疫苗。从 2009 年 10 月至 2014 年,共有 3628 例新的癫痫病例(发病率为 6.09/10 000人年)。接种疫苗后癫痫发作的风险没有增加:风险比:1.07;95%置信区间:0.94-1.23。自我对照病例系列分析的结果支持疫苗接种与随后癫痫之间没有关联的发现。
大流行性流感疫苗接种与癫痫风险增加无关。关于大流行性疫苗接种会导致儿童癫痫的担忧似乎是没有根据的。